Chronic Helicobacter pylori infection is associated with peripheral arterial disease

Journal of Infection and Chemotherapy

Volumn 14, Issue 3, 2008, Pages 250-254

  Sawayama, Yasunori ^a   Hamada, Maki ^a   Otaguro, Shigeru ^a   Maeda, Shinji ^a   Ohnishi, Hachiro ^a   Fujimoto, Yayoi ^a   Taira, Yuji ^b   Hayashi, Jun ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b HARASANSHIN HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Helicobacter pylori; Peripheral arterial disease (PAD)

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; UREA BREATH TEST;

EID: 45749108636     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-008-0613-4     Document Type: Article

References (24)

1. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-439.
2. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-436.
3. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126.
4. Maeda N, Sawayama Y, Tatsukawa M, Shimizu C, Kashiwagi S, Hayashi J. Chlamydia pneumoniae seropositivity and early carotid atherosclerosis in a suburban Japanese population. Atherosclerosis 2002;164:313-319.
5. Tatsukawa M, Sawayama Y, Maeda N, Okada K, Furusyo N, Kashiwagi S, et al. Carotid atherosclerosis and cardiovascular risk factors: a comparison of residents of a rural area of Okinawa with residents of a typical suburban area of Fukuoka, Japan. Atherosclerosis 2004;172:337-343.
6. Okada K, Maeda N, Tatsukawa M, Shimizu C, Sawayama Y, Hayashi J. The influence of lifestyle modification on carotid artery intima-media thickness in a suburban Japanese population. Atherosclerosis 2004;173:329-337.
7. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999;19:538-545.
8. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996;348:329-339.
9. Sawayama Y, Hamada M, Otaguro Y, Maeda S, Ohnishi H, Taira T, et al. The impact of peripheral arterial disease and acute ischemic stroke. Fukuoka Igaku Zasshi. 2006;97:293-301.
10. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-986.
11. Sawayama Y, Ariyama I, Hamada M, Otaguro S, Machi T, Taira Y, et al. Association between chronic Helicobacter pylori infection and acute ischemic stroke: Fukuoka Harasanshin Atherosclerosis Trial (FHAT). Atherosclerosis. 2005;178:303-309.
12. Ito M, Mishima Y. Risk factor, natural history and prognosis of the patients with arteriosclerosis obliterans. Nippon Geka Gakkai Zasshi 1996;97:476-480.
13. 13C-urea breath test. Clin Infect Dis 1997;25:1003-1005.
14. 2 infrared analyzer: comparison between infrared spectrometric analysis and mass spectrometric analysis. Helicobacter 1998;3:49-53.
15. Dixon MF, Gentra RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996;20:1161-1181.
16. Yamashina A, Tomiyama H, Takeda H, Tsuda H, Arai T, Hirose R, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002;25:359-364.
17. Fujimoto Y, Furusyo N, Toyoda K, Takeoka H, Sawayama Y, Hayashi J. Intrafamilial transmission of Helicobacter pylori among the population of endemic areas of Japan. Helicobacter 2007;12:170-176.
18. Sawayama Y, Shimizu C, Maeda N, Tatsukawa M, Kinukawa N, Koyanagi S, et al. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST). J Am Coll Cardiol 2002;20;39:610-616.
19. Sawayama Y, Tatsukawa M, Okada K, Maeda N, Shimizu C, Kikuchi K, et al. Association of Chlamydia pneumoniae antibody with the cholesterol-lowering effect of statins. Atherosclerosis 2003;171:281-285.
20. Salomaa V, Niemela M, Miettinen H, Ketonen M, Immonen-Raiha P, Koskinen S, et al. Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation 2000;101:1913-1918.
21. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998;316:1130-1132.
22. Maeda S, Kanai F, Ogura K, Yoshida H, Ikenoue T, Takahashi M, et al. High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan. Dig Dis Sci 1997;42:1841-1847.
23. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 2001;32:385-391.
24. Stone AF, Mendall MA, Kaski JC, Edger TM, Risley P, Poloniecki J, et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation 2002;106:1219-1223.